White label ELPA - ClinicalTrials.eu

Study on Improving Burn Scars with Adipose-Derived Stem Cells and Autologous Stromal Vascular Fraction for Patients with Hypertrophic Scarring

Not yet recruiting

1 1
Investigated diseases:
- Hypertrophic scar
Investigated drugs:
- Adrc001
Study on Nivolumab and MesoPher for Patients with Peritoneal Mesothelioma

Not yet recruiting

2 1 1 1
Investigated diseases:
- Peritoneal mesothelioma malignant
Investigated drugs:
- AUTOLOGOUS DENDRITIC CELLS LOADED WITH ALLOGENIC ALLOGENEIC LYSATE OF MESOTHELIOMA CELL LINES
- Nivolumab
Study on Colchicine and Tiemonium Methylsulphate for Reducing Atherosclerosis in Cancer Patients Undergoing Immune Therapy

Not yet recruiting

3 1 1 1
Investigated diseases:
- Arteriosclerosis
- Neoplasm malignant
Investigated drugs:
Study of ETX-19477 for Patients with Advanced Solid Tumors After Standard Treatment

Not yet recruiting

2 1 1
Investigated diseases:
Investigated drugs:
- ETX-19477
Study on Relugolix and Radiation Therapy for Patients with Intermediate Risk Prostate Cancer

Not yet recruiting

2 1 1 1
Investigated diseases:
- Prostate cancer
Investigated drugs:
- Relugolix
Study of IOMX-0675 alone or combined with pembrolizumab for patients with previously treated advanced or metastatic solid tumors

Not yet recruiting

1 1 1 1
Investigated drugs:
- Pembrolizumab
A study of orismilast alone or combined with semaglutide for weight management in people with obesity

Not yet recruiting

2 1 1
Investigated diseases:
- Obesity
Investigated drugs:
- Orismilast
- Semaglutide
Study on Thiopental Sodium Dose During Electroconvulsive Therapy for Patients with Major Depressive Disorder

Not yet recruiting

3 1 1 1
Investigated diseases:
- Major depression
Investigated drugs:
- Thiopental Sodium
Study of Momelotinib and Luspatercept for Patients with Transfusion-Dependent Myelofibrosis

Not yet recruiting

2 1 1 1
Investigated diseases:
- Primary myelofibrosis
Investigated drugs:
- Luspatercept
- Momelotinib Dihydrochloride Monohydrate
Study of Cabozantinib for Patients with Non-Small Cell Lung Cancer and MET Deregulation

Not yet recruiting

2 1 1 1
Investigated drugs:
- Cabozantinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies